- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-09-02-2009
Pharmaceutical Technology
Pharmaceutical Technology, September 2009 Issue (PDF)
September 02, 2009
Issue PDF
33
9
Robots Lend a Hand
Pharma Capsules
September 02, 2009
Pharma Capsules
33
9
Brief pharmaceutical news items for September 2009.
Q&A with Timothy Oostdyk, Executive Vice-President and Chief Operating Officer of Lancaster Laboratores
September 02, 2009
Industry Leaders: Q&A
33
9
Oostdyk discusses the latest industry developments and trends.
Of Audits and Gunk
September 02, 2009
Agent-In-Place
33
9
Thanks to their keen observations, these auditors reveal the true culprits of deviations.
Quality by Enforcement
September 02, 2009
From The Editor
33
9
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
Robots: The Next Phase in Pharmaceutical Automation
September 02, 2009
Special Report
33
9
Robotic systems provide flexibility and efficiency (and they're not as difficult to use as you think). This article contains bonus online-exclusive material.
It's Easy Being Green
September 02, 2009
Online Exclusives
33
9
An outstanding new book reviews alternative solvents with an eye to sustainable pharmaceutical processes.
Expansion Plan
September 02, 2009
Outsourcing Outlook
33
9
Contract-service providers are expanding their offerings in this slow-growth environment.
A Green Manufacturing Route to Testosterone
September 02, 2009
Online Exclusives
33
9
A second-generation and green manufacturing process for testosterone provided economic and ecological benefits.
In the Spotlight September 2009
September 02, 2009
In the Spotlight
33
9
Editors' Picks of Pharmaceutical Science & Technology Innovations
Pill-Level Product Protection
September 02, 2009
Packaging Forum
33
9
Authenticating tools help identify counterfeit drug products. This article contains bonus online-exclusive material.
A Brave New Path for Pharma
September 02, 2009
Viewpoint
33
9
Personalized medicine and integrated healthcare delivery require new business and pricing models. This article contains bonus online-exclusive material.
Tracking CMO Activity
September 02, 2009
Ingredients Insider
33
9
Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.
Global Health Concerns Create Business Opportunities
September 02, 2009
Washington Report
33
9
Health crises generate support for new vaccines and treatments for diseases found in developing nations.
Inside ICH–MHLW: Working Groups Ramp up Quality-based Implementation
September 02, 2009
Inside ICH
33
9
Representatives of Japan's MHLW report on recent ICH activities and what the ministry expects from Q11.
Green API Manufacturing
September 02, 2009
Special Report
33
9
Pfizer uses green-chemistry in a second-generation manufacturing route for gabapentin.
Evaluating Functional Equivalency as a Lyophilization Cycle Transfer Tool
September 02, 2009
Peer-Reviewed Research
33
9
The authors describe a comprehensive methodology for establishing functional equivalence among various lyophilizers.
The Go/No-Go Mindset
September 02, 2009
PharmTech Talk
33
9
As new process validation guidelines emerge, industry needs to reinvent how it releases product.
Inside IPEC–Americas: Evaluating Excipient Stability
September 02, 2009
Inside IPEC
33
9
IPEC's new stability testing guide takes into account the full supply chain's storage conditions.
Drug Master Files: Requirements and Challenges
September 02, 2009
Online Exclusives
33
9
The author describes several issues in creating drug master files and active substance files for active pharmaceutical ingredients and intermediates.
Report From: Brazil
September 02, 2009
News
33
9
Designated as a "pharmerging market," Brazil is revamping its pricing models.